The immune system comprises organs, tissues, cells and molecules, which protect the body against pathogens.
Detailed description
The biological defense system can be separated into an innate and an adaptive part. The innate immune system developed early in the phylogeny of living things. The adaptive immune system adjusts to new or modified pathogens. Both parts collaborate closely. Moreover, the immune system can destroy abnormal or defective cells of the own body.
Colombia currently houses several million refugees and migrants, of whom 1.8 million are from Venezuela. The success of the country’s pandemic control measures will depend on the careful monitoring of
Please use this image only in connection with this news.
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide collaboration. But medications against Covid-19 have as yet seen only partial success. A Munich research
This year, the German Center for Infection Research (DZIF) is honouring the medical scientist and clinical virologist Prof. Ulrike Protzer for her scientific achievements. The prize is endowed with
Researchers at Karolinska Institutet, Umeå University, and DZIF scientists at the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic
Bitte verwenden Sie dieses Bild nur im Zusammenhang mit dieser Pressemitteilung.
While the highly infectious SARS-CoV-2 Delta variant has already become predominant in Germany and in most European nations, little was known about its spread in Africa. German Center for Infection
The right therapy for the right patient group at the right time - that is what precision medicine makes possible. In the current issue of the DZG magazine SYNERGIE, the German Centers for Health
Paediatrician and DZIF scientist Dr Julia Pagel, Universität zu Lübeck, will receive EUR 50,000 to expand her research on lung diseases in infants. The prize is awarded by the North German Cluster of
Please use this picture only in connection with the press release.
The clinical review of the MVA-SARS-2-S vector vaccine against COVID-19 will continue with a new version. The DZIF (German Center for Infection Research) scientists temporarily suspended the study